Stay updated with breaking news from Nucleus Network. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Inhalon Biopharma, Inc., a clinical-stage immunotherapy company developing an inhaled "muco-trapping" antibody platform for treating acute...
Australian medical research house Burnet Institute has secured a giant payday for its clinical research testing spin-off, 360biolabs,
New model could help test vaccines against the deadly Strep A bacteria Researchers have successfully developed a new Strep A human challenge model, paving the way to test vaccines against the common deadly bacteria that causes sore throats, scarlet fever and skin sores. The collaborative research effort, led by the Murdoch Children's Research Institute (MCRI) and published in The Lancet Microbe, found the model, which deliberately infected healthy adult volunteers with the bacteria in a controlled environment, was safe and would now be used to trial Strep A candidate vaccines. Strep A infect...
A leading Australian infectious diseases and vaccine expert has answered some of the growing questions about the country's vaccine rollout, including the topic of choosing between AstraZeneca and Pfizer. 9News talked with Associate Professor Paul Griffin, who has worked on COVID's frontline at the Mater Hospital in Brisbane. He has overseen more than 100 clinical trials of vaccine as a part of the Nucleus Network. READ MORE: 9News sat down with Associate Professor Paul Griffin, who has worked on COVID's frontline at the Mater Hospital in Brisbane. (Nine) With the number of blood clotting case...
Researchers have successfully developed a new Strep A human challenge model, paving the way to test vaccines against the common deadly bacteria that causes sore throats, scarlet fever and skin sores.